loadpatents
name:-0.063723087310791
name:-0.04883599281311
name:-0.018140077590942
Horstmann; Michael Patent Filings

Horstmann; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Horstmann; Michael.The latest application filed is for "adapter system comprising a frame, active ingredient pad and lid".

Company Profile
19.60.54
  • Horstmann; Michael - Neuwied DE
  • Horstmann; Michael - Andernach DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Water-vapor-permeable adhesive bandages
Grant 11,291,745 - Horstmann , et al. April 5, 2
2022-04-05
Composition for transdermal delivery of cationic active agents
Grant 10,881,606 - Schmitz , et al. January 5, 2
2021-01-05
Composition for transdermal delivery of cationic active agents
Grant 10,881,607 - Schmitz , et al. January 5, 2
2021-01-05
Transdermal therapeutic system for the administration of peptides
Grant 10,772,845 - Horstmann , et al. Sept
2020-09-15
Adapter System Comprising A Frame, Active Ingredient Pad And Lid
App 20200179666 - HORSTMANN; Michael ;   et al.
2020-06-11
Composition for Transdermal Delivery of Cationic Active Agents
App 20200113819 - SCHMITZ; Christoph ;   et al.
2020-04-16
Transdermal therapeutic system comprising active ingredient particles and having increased active ingredient flux
Grant 10,596,126 - Horstmann , et al.
2020-03-24
Transdermal therapeutic system for the administration of peptides
Grant 10,471,021 - Horstmann , et al. Nov
2019-11-12
Transdermal Therapeutic System with a Low Tendency to Spontaneously Crystallize
App 20190328680 - Dzekan; Horst ;   et al.
2019-10-31
Transdermal Administration Of Memantine
App 20190298662 - EIFLER; Rene ;   et al.
2019-10-03
Transdermal Therapeutic System for 5-Aminolevulinic Acid Hydrochloride
App 20190240166 - JUNG; Tobias ;   et al.
2019-08-08
Transdermal Therapeutic System Comprising Active Ingredient Particles And Having Increased Active Ingredient Flux
App 20190231710 - HORSTMANN; Michael ;   et al.
2019-08-01
Transdermal administration of memantine
Grant 10,363,228 - Eifler , et al.
2019-07-30
Transdermal Therapeutic System For Administering The Active Substance Buprenorphine
App 20190192506 - Hille; Thomas ;   et al.
2019-06-27
Device with transdermal therapeutic system, and positioning aid and penetration aid
Grant 10,315,020 - Wortmann , et al.
2019-06-11
Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride
Grant 10,307,382 - Jung , et al.
2019-06-04
Transdermal therapeutic system comprising active ingredient particles and having increased active ingredient flux
Grant 10,292,942 - Horstmann , et al.
2019-05-21
Water-vapor-permeable Adhesive Bandages
App 20190134254 - HORSTMANN; Michael ;   et al.
2019-05-09
Transdermal Therapeutic System For Administering The Active Substance Buprenorphine
App 20180289698 - Hille; Thomas ;   et al.
2018-10-11
Transdermal therapeutic system for the administration of peptides
App 20180133165 - HORSTMANN; Michael ;   et al.
2018-05-17
Transdermal therapeutic system for the administration of peptides
Grant 9,895,319 - Horstmann , et al. February 20, 2
2018-02-20
Transdermal Therapeutic System For Administering The Active Substance Buprenorphine
App 20170224676 - Hille; Thomas ;   et al.
2017-08-10
Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy
Grant 9,717,698 - Horstmann , et al. August 1, 2
2017-08-01
Polyamine Enhanced Formulations For Triptan Compound Iontophoresis
App 20170112779 - Sebree; Terri B. ;   et al.
2017-04-27
Transdermal Therapeutic System With High Rate Of Utilization Of Active Substance And Dosing Accuracy
App 20160324799 - HORSTMANN; Michael ;   et al.
2016-11-10
Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy
Grant 9,421,174 - Horstmann , et al. August 23, 2
2016-08-23
Three-layer Transdermal Therapy System (tts)
App 20160199316 - BREITENBACH; Armin ;   et al.
2016-07-14
Transdermal Therapeutic System For Administering The Active Substance Buprenorphine
App 20160175447 - Hille; Thomas ;   et al.
2016-06-23
Device With Transdermal Therapeutic System, And Positioning Aid And Penetration Aid
App 20160166820 - WORTMANN; UWE ;   et al.
2016-06-16
Transdermal therapeutic system for administering the active substance buprenorphine
Grant 9,308,202 - Hille , et al. April 12, 2
2016-04-12
Transdermal Therapeutic System With High Rate Of Utilization Of Active Substance And Dosing Accuracy
App 20150238437 - HORSTMANN; Michael ;   et al.
2015-08-27
Transdermal therapeutic system reinforced by ultrasounds
Grant 9,114,240 - Horstmann , et al. August 25, 2
2015-08-25
Transdermal therapeutic system comprising ion pair microreservoirs
Grant 9,089,527 - Hille , et al. July 28, 2
2015-07-28
Transdermal Therapeutic System
App 20150190349 - HORSTMANN; Michael
2015-07-09
Transdermal therapeutic system having urea components
Grant 9,066,887 - Horstmann , et al. June 30, 2
2015-06-30
Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy
Grant 9,056,026 - Horstmann , et al. June 16, 2
2015-06-16
Transdermal pharmaceutical preparation containing active substance combinations, for treating Parkinson's disease
Grant 8,980,308 - Horstmann , et al. March 17, 2
2015-03-17
Transdermal Therapeutic System With A Low Tendency To Spontaneously Crystallize
App 20140378917 - Dzekan; Horst ;   et al.
2014-12-25
Transdermal therapeutic system having stabilized membrane
Grant 8,882,729 - Horstmann , et al. November 11, 2
2014-11-11
Method for producing individually dosed active substance-containing and, in particular, aromatics-containing film-shaped administration forms rapidly disintegrating upon contact with liquid
Grant 8,883,191 - Horstmann , et al. November 11, 2
2014-11-11
Transdermal Therapeutic System For 5-aminolevulinic Acid Hydrochloride
App 20140323994 - Jung; Tobias ;   et al.
2014-10-30
Polyamine Enhanced Formulations For Triptan Compound Iontophoresis
App 20130245535 - Sebree; Terri B. ;   et al.
2013-09-19
Non-reclosable package for products prejudicial to health, as well as process for its production
Grant 8,534,461 - Ludwig , et al. September 17, 2
2013-09-17
Non-Reclosable Package for Products Prejudicial to Health, as well as Process for its Production
App 20130062244 - Ludwig; Karin ;   et al.
2013-03-14
Polyamine enhanced formulations for triptan compound iontophoresis
Grant 8,366,600 - Sebree , et al. February 5, 2
2013-02-05
Non-reclosable package for products prejudicial to health, as well as process for its production
Grant 8,307,983 - Ludwig , et al. November 13, 2
2012-11-13
Transdermal Therapeutic System for the Administration of Peptides
App 20120245538 - Horstmann; Michael ;   et al.
2012-09-27
Transdermal Therapeutic System Having Stabilized Membrane
App 20120245537 - Horstmann; Michael ;   et al.
2012-09-27
Transdermal therapeutic System for the Administration of Peptides
App 20120238942 - Horstmann; Michael ;   et al.
2012-09-20
Water-vapor Permeable Adhesive Bandages
App 20120109033 - Horstmann; Michael ;   et al.
2012-05-03
Transdermal administration of memantine
App 20110313372 - EIFLER; Rene ;   et al.
2011-12-22
Composition For Transdermal Delivery Of Cationic Active Agents
App 20110111029 - Schmitz; Christoph ;   et al.
2011-05-12
Transdermal Therapeutic System With High Rate Of Utilization Of Active Substance And Dosing Accuracy
App 20110020407 - Horstmann; Michael ;   et al.
2011-01-27
Method and device for improving the permeability of the human skin
Grant 7,858,113 - Horstmann December 28, 2
2010-12-28
Transdermal Therapeutic System Having Urea Components
App 20100310634 - Horstmann; Michael ;   et al.
2010-12-09
Transdermal Therapeutic System for Volatile and/or Thermo-Labile Substances
App 20100166836 - Jung; Tobias ;   et al.
2010-07-01
Transdermal Therapeutic System For Administering The Active Substance Buprenorphine
App 20100119585 - Hille; Thomas ;   et al.
2010-05-13
Transdermal Therapeutic System Comprising Ion Pair Microreservoirs
App 20100112064 - Hille; Thomas ;   et al.
2010-05-06
Transdermal Therapeutic System For Administering Water-soluable Active Ingredients
App 20100028412 - Asmussen; Bodo ;   et al.
2010-02-04
Monitoring system for collecting and/or transdermally rediffusing air containing environmental contaminants, and corresponding method
Grant 7,640,816 - Horstmann , et al. January 5, 2
2010-01-05
Polyamine enhanced formulations for triptan compound iontophoresis
App 20090318847 - Sebree; Terri B. ;   et al.
2009-12-24
Transdermal Therapeutic System Comprising Active Ingredient Particles and Having Increased Active Ingredient Flux
App 20090258062 - Horstmann; Michael ;   et al.
2009-10-15
Transdermal Therapeutic System Reinforced By Ultrasounds
App 20090192431 - Horstmann; Michael ;   et al.
2009-07-30
Transdermal therapeutic system with a highly effective neuroleptic agent
Grant 7,560,121 - Bracht , et al. July 14, 2
2009-07-14
Non-Reclosable Package for Products Prejudicial to Health, as well as Process for its Production
App 20080105582 - Ludwig; Karin ;   et al.
2008-05-08
Monitoring System For Collecting And/Or Transdermally Rediffusing Air Containing Environmental Contaminants, And Corresponding Method
App 20070289360 - Horstmann; Michael ;   et al.
2007-12-20
Device for transdermal administration of active substances
App 20070081977 - Horstmann; Michael
2007-04-12
Inhaler for basic pharmaceutical agents and method for the production thereof
App 20070062548 - Horstmann; Michael ;   et al.
2007-03-22
Method and device for inserting a plurality of individual sheetlike forms of administration in a dispenser by forming a multilayer pile
Grant 7,175,172 - Steinborn , et al. February 13, 2
2007-02-13
Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease
App 20070026054 - Theobald; Frank ;   et al.
2007-02-01
Method and device for improving the permeability of the human skin
App 20070020323 - Horstmann; Michael
2007-01-25
Direct coating method
App 20060244175 - Horstmann; Michael
2006-11-02
Devices and methods for heat-pulse assisted thermal applications of active subtances
App 20040219192 - Horstmann, Michael ;   et al.
2004-11-04
Method for producing film-type dosage
Grant 6,800,329 - Horstmann , et al. October 5, 2
2004-10-05
Method for producing individually dosed active substance-containing and, in particular, aromatics-containing film-shaped administration forms rapidly disintegrating upon contact with liquid
App 20040137027 - Horstmann, Michael ;   et al.
2004-07-15
Method for producing film-type dosage
App 20040126497 - Horstmann, Michael ;   et al.
2004-07-01
Method and device for inserting a plurality of individual sheetlike forms of administration in a dispenser by forming a multilayer pile
App 20040046305 - Steinborn, Peter ;   et al.
2004-03-11
Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance
Grant 6,682,756 - Horstmann , et al. January 27, 2
2004-01-27
Method and device for inserting a plurality of individual sheetlike forms of administration in a dispenser by forming a multilayer pile
Grant 6,659,442 - Steinborn , et al. December 9, 2
2003-12-09
Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-.beta.-estradiol to the human organism
Grant 6,623,763 - Asmussen , et al. September 23, 2
2003-09-23
Method for producing film-type dosage
App 20030087034 - Horstmann, Michael ;   et al.
2003-05-08
Transdermal therapeutic system containing estradiol
Grant 6,521,250 - Meconi , et al. February 18, 2
2003-02-18
Transdermal Therapeutic system containing estradiol
App 20020012691 - Meconi, Reinhold ;   et al.
2002-01-31
TTS containing an antioxidant
App 20010048938 - Asmussen, Bodo ;   et al.
2001-12-06
Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17- beta -estradiol to the human organism
App 20010043944 - Asmussen, Bodo ;   et al.
2001-11-22
Surface-stabilized pharmaceutical preparation for application on the skin
Grant 6,207,183 - Horstmann , et al. March 27, 2
2001-03-27
Transdermal therapeutic system containing estradiol
Grant 6,143,319 - Meconi , et al. November 7, 2
2000-11-07
Transdermal therapeutic system for administering active agents to the human body via the skin
Grant 6,074,665 - Horstmann , et al. June 13, 2
2000-06-13
Transdermal therapeutic system for the release of 17-.beta.-estradiol and process for its production
Grant 5,912,008 - Horstmann , et al. June 15, 1
1999-06-15
Estradiol-TTS having water-binding additives
Grant 5,902,602 - Muller , et al. May 11, 1
1999-05-11
Transdermal therapeutic system exhibiting an increased active substance flow and process for the production thereof
Grant 5,702,721 - Horstmann , et al. December 30, 1
1997-12-30
Galvanically active transdermal therapeutic system
Grant 5,685,837 - Horstmann November 11, 1
1997-11-11
Rapidly disintegrating sheet-like presentations of multiple dosage units
Grant 5,629,003 - Horstmann , et al. May 13, 1
1997-05-13
Transdermal therapeutic system comprising tulobuterol as active substance
Grant 5,254,348 - Hoffmann , et al. October 19, 1
1993-10-19
Transdermal therapeutic system exhibiting an increased active substance flow and process for the production thereof
Grant 5,230,898 - Horstmann , et al. July 27, 1
1993-07-27
Transdermal therapeutic system
Grant 4,882,163 - Guse , et al. November 21, 1
1989-11-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed